ANTIBODIES AGAINST HMGB1, AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE

An anti-HMGB1 antibody comprising a light chain variable region comprising complementarity-determining regions or the like including amino acid sequences of SEQ ID NOs: 4 to 6, and a heavy chain variable region comprising complementarity-determining regions or the like including amino acid sequences...

Full description

Saved in:
Bibliographic Details
Main Authors OKAZAWA, Hitoshi, KAJIKAWA, Masunori
Format Patent
LanguageEnglish
Published 11.07.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract An anti-HMGB1 antibody comprising a light chain variable region comprising complementarity-determining regions or the like including amino acid sequences of SEQ ID NOs: 4 to 6, and a heavy chain variable region comprising complementarity-determining regions or the like including amino acid sequences of SEQ ID NOs: 10 to 12, or an anti-HMGB1 antibody comprising a light chain variable region or the like comprising an amino acid sequence of SEQ ID NO: 3, and a heavy chain variable region comprising an amino acid sequence or the like of SEQ ID NO: 9, and a composition for treating or preventing Alzheimer's disease, comprising the same as an active ingredient.
AbstractList An anti-HMGB1 antibody comprising a light chain variable region comprising complementarity-determining regions or the like including amino acid sequences of SEQ ID NOs: 4 to 6, and a heavy chain variable region comprising complementarity-determining regions or the like including amino acid sequences of SEQ ID NOs: 10 to 12, or an anti-HMGB1 antibody comprising a light chain variable region or the like comprising an amino acid sequence of SEQ ID NO: 3, and a heavy chain variable region comprising an amino acid sequence or the like of SEQ ID NO: 9, and a composition for treating or preventing Alzheimer's disease, comprising the same as an active ingredient.
Author KAJIKAWA, Masunori
OKAZAWA, Hitoshi
Author_xml – fullname: OKAZAWA, Hitoshi
– fullname: KAJIKAWA, Masunori
BookMark eNqNir0OgjAURjvo4N87NHFw0YTixHiBC9zEtqS3OrgQYmocDJDg-0clPoDTOefLtxSzru_CQjzAeEptTsgSSiDDXla6TNVegsllZnVtmTxZM7kjJlNKBo2ysE56h-C_y8drhxc0U8HpWiFpdDuWOTEC41rM7-1zDJsfV2JboM-qQxj6JoxDewtdeDVnjiOVxEpFSQzq-N_rDT_cOCQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2019211092A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2019211092A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:52:48 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2019211092A13
Notes Application Number: US201716324192
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190711&DB=EPODOC&CC=US&NR=2019211092A1
ParticipantIDs epo_espacenet_US2019211092A1
PublicationCentury 2000
PublicationDate 20190711
PublicationDateYYYYMMDD 2019-07-11
PublicationDate_xml – month: 07
  year: 2019
  text: 20190711
  day: 11
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies National University Corporation Tokyo Medical and Dental University
RelatedCompanies_xml – name: National University Corporation Tokyo Medical and Dental University
Score 3.2121234
Snippet An anti-HMGB1 antibody comprising a light chain variable region comprising complementarity-determining regions or the like including amino acid sequences of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title ANTIBODIES AGAINST HMGB1, AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190711&DB=EPODOC&locale=&CC=US&NR=2019211092A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1dS8MwFA1jivqmU_FjSkCZLxbXrmvtw5C0zdaKbUfTjeHLyJoOBemGq_j3vQmb-rS3mwRCcuHknnPzhdBt4RSSKuiaYxm5ZkKA1bgtulpeOKIt5tzuzNUB2dgKRubzpDupoY_NXRj1Tui3ehwREJUD3iu1Xi__kli-Olu5epi9Q9XiqZ_1_NZaHUN0swG7vtujw8RPvJbn9UasFaeqTWodxyCglXaASNsSD3Tsynspy_9BpX-IdofQX1kdoVpRNtC-t_l7rYH2ovWWN5hr9K2O0RuJs9BNJIPDZEBAd2c4iAaufo9J7GMviYYJC2XOSdlpyMJ4gBmJKAath7OUkkzWgA2OH9NYlcjLa0DDiKZ3DPsho4TRE3TTp5kXaDDk6a-HpiP2f36dU1QvF2VxhrCZG_Ou89jmDhem4IKbJgeGalvCEECrrXPU3NbTxfbmS3QgizLVqetNVK8-v4oriNHV7Fq59gfjUoxM
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwEA5DxfmmU_HH1IAyXyyuXdfahyFpm63VtR1NN4Yvo2s6FKQbruK_7yVsuqe9XXMQ2oMv933XXILQXW7lgiqoimVomaJDglVSk7eVLLd4k89SszWTG2RDwxvqL-P2uII-170w8pzQH3k4IiAqA7yXcr1e_BexXLm3cvk4_YCh-XM36biNlTqG7GYCdl27QweRGzkNx-kMWSOMpU9oHUsjoJV2gWSbAg90ZIu-lMVmUukeor0BzFeUR6iSFzVUddZ3r9XQfrD65Q3mCn3LY_ROwsS3I8HgMOkR0N0J9oKerT5gErrYiYJBxHxRc5J27DM_7GFGAopB6-EkpiQRI2BD4Ec0lE-k_-ZRP6DxPcOuzyhh9ATddmnieAq88uQvQpMh2_y-1inaKeZFfoawnmmztvXUTK2U6zzlqa6nwFBNg2scaLVxjurbZrrY7r5BVS8J-pO-H75eogPhEmVPVa2jnfLrO7-CfF1Or2WYfwGk0I8_
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTIBODIES+AGAINST+HMGB1%2C+AND+COMPOSITION+COMPRISING+SAME+FOR+TREATING+OR+PREVENTING+ALZHEIMER%27S+DISEASE&rft.inventor=OKAZAWA%2C+Hitoshi&rft.inventor=KAJIKAWA%2C+Masunori&rft.date=2019-07-11&rft.externalDBID=A1&rft.externalDocID=US2019211092A1